Fundraising FoxVOCxi
Arden Hills, US · Founded 2022 · 6 known investors
Find your way into VOCxi
Each arrow is one introduction. Sign up to fill in the first one.
You →IC · together at Vocxi Health →Ping
Ask Jamie Chen to introduce you to Greg Peterson
You →Jamie · together at Vocxi Health →Greg
Sign up to find every way you can get introduced to VOCxi
- Your email: who you already know at VOCxi, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the VOCxi team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Vocxi Health develops MyBreathPrint, a noninvasive breath-analysis device that detects volatile organic compounds to screen for lung cancer and other diseases early. The system uses nanotechnology and machine learning to provide immediate diagnostic results without needles, radiation, or surgery.
Founders & leadership
Board
Investors · 6
How we know: Alliance of Angels's portfolio page · Not right? Tell us
How we know: Great North Ventures's portfolio page · Not right? Tell us
How we know: GROOVE CAPITAL's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Samsung Next's portfolio page · Not right? Tell us
How we know: Taiwan Global Angels's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$4.7M disclosed across 2 rounds · 2022–2024
▶$800KraisedJul 2024 · 8 investors · Other Health CareRule 506(b)
- Morgan EvansDirector
- Greg SherwoodExecutive Officer, Director, Promoter
- Randy SchiestlExecutive Officer, Director, Promoter
- Yung-Ping YehExecutive Officer, Director, Promoter
- Offering amount
- $2.5M
- Amount sold
- $800K
- Minimum investment
- $25K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$3.9MraisedSep 2023 · 13 investors · Other Health CareRule 506(b)
- Randy SchiestlExecutive Officer, Director
- Greg SherwoodExecutive Officer, Director
- Morgan EvansDirector
- Yung-Ping YehExecutive Officer, Director
- Offering amount
- $6.5M
- Amount sold
- $3.9M
- Minimum investment
- $25K
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does VOCxi do?
- Vocxi Health develops MyBreathPrint, a noninvasive breath-analysis device that detects volatile organic compounds to screen for lung cancer and other diseases early. The system uses nanotechnology and machine learning to provide immediate diagnostic results without needles, radiation, or surgery.
- Who are VOCxi's investors?
- VOCxi's investors include Alliance of Angels, Great North Ventures, GROOVE CAPITAL, Samsung Next, Taiwan Global Angels, Kitchen Fund.
- How much funding has VOCxi raised?
- VOCxi has disclosed $4.7M raised across 2 rounds.
- Where is VOCxi headquartered?
- VOCxi is headquartered in Arden Hills, US.